Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

TRAZODONE HYDROCHLORIDE

14 general benefit · 3 not a benefit

Other products in the same Health Canada class (N06AX) — coverage varies; not interchangeable

  • Duloxetine (Cymbalta): general benefit, Not a benefit
  • Mirtazapine (Remeron RD): general benefit, Not a benefit
  • Venlafaxine (Effexor XR): general benefit
  • Vortioxetine (Trintellix): general benefit
  • Bupropion (Wellbutrin XL): limited Use 315, Not a benefit
  • Desvenlafaxine (Pristiq): not a benefit

17 more in the class list below

Apo-Trazodone · DIN 02147637 · 50mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Trazodone · DIN 02147637 Manufacturer: Apotex Inc.; listing date 1996-10-01 Health Canada: Marketed since 1995-12-31 · brand APO-TRAZODONE TABLETS 50MG · ATC N06AX05 TRAZODONE · form Tablet · route Oral · ingredients TRAZODONE HYDROCHLORIDE 50 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Trazodone: Formulary list price $0.0554/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0554 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18046 · Verify on the e-Formulary ↗ (DIN 02147637)

Source record
DIN 02147637: Apo-Trazodone Raw flags: sec3=Y Item: 281604040; group id 472; item number 1185; lccId None; manufacturer id APX Source form: Tab; strength: 50mg Recorded listing: General benefit Source prices (unrounded): $0.0554; ministry $0.0554 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02147637 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18046
Interchangeable products
Desyrel · DIN 00579351 · not recorded Jamp Trazodone · DIN 02442809 · $0.0554 PMS-Trazodone · DIN 01937227 · $0.0554 Teva-Trazodone · DIN 02144263 · $0.0554 Trazodone · DIN 02348772 · $0.0554
Shortage status: shortage reported ended 2026-08-28 (report last updated 2026-08-28); confirm supply with the pharmacy; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02147637
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Jamp Trazodone · DIN 02442809 · 50mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp Trazodone · DIN 02442809 Manufacturer: Jamp Pharma Corporation; listing date 2022-01-31 Health Canada: Marketed since 2021-12-07 · brand JAMP TRAZODONE · ATC N06AX05 TRAZODONE · form Tablet · route Oral · ingredients TRAZODONE HYDROCHLORIDE 50 MG · company Jamp pharma corporation · schedule Prescription
Check this DIN again · Health Canada product record

Jamp Trazodone: Formulary list price $0.0554/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0554 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=92726 · Verify on the e-Formulary ↗ (DIN 02442809)

Source record
DIN 02442809: Jamp Trazodone Raw flags: sec3=Y Item: 281604040; group id 472; item number 1185; lccId None; manufacturer id JPC Source form: Tab; strength: 50mg Recorded listing: General benefit Source prices (unrounded): $0.0554; ministry $0.0554 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02442809 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=92726
Interchangeable products
Apo-Trazodone · DIN 02147637 · $0.0554 Desyrel · DIN 00579351 · not recorded PMS-Trazodone · DIN 01937227 · $0.0554 Teva-Trazodone · DIN 02144263 · $0.0554 Trazodone · DIN 02348772 · $0.0554
Shortage status: resolved shortage (ended 2023-08-08); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02442809
Shortage record checked 2026-09-13T08:10:21.292534+00:00

PMS-Trazodone · DIN 01937227 · 50mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
PMS-Trazodone · DIN 01937227 Manufacturer: Pharmascience Inc.; listing date 1996-10-01 Health Canada: Marketed since 1993-12-31 · brand PMS TRAZODONE HCL TAB 50MG · ATC N06AX05 TRAZODONE · form Tablet · route Oral · ingredients TRAZODONE HYDROCHLORIDE 50 MG · company Pharmascience inc · schedule Prescription
Check this DIN again · Health Canada product record

PMS-Trazodone: Formulary list price $0.0554/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0554 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=4241 · Verify on the e-Formulary ↗ (DIN 01937227)

Source record
DIN 01937227: PMS-Trazodone Raw flags: sec3=Y Item: 281604040; group id 472; item number 1185; lccId None; manufacturer id PMS Source form: Tab; strength: 50mg Recorded listing: General benefit Source prices (unrounded): $0.0554; ministry $0.0554 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=01937227 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=4241
Interchangeable products
Apo-Trazodone · DIN 02147637 · $0.0554 Desyrel · DIN 00579351 · not recorded Jamp Trazodone · DIN 02442809 · $0.0554 Teva-Trazodone · DIN 02144263 · $0.0554 Trazodone · DIN 02348772 · $0.0554
Shortage status: resolved shortage (ended 2024-04-10); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01937227
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Teva-Trazodone · DIN 02144263 · 50mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Teva-Trazodone · DIN 02144263 Manufacturer: Teva Canada Limited; listing date 1996-10-01 Health Canada: Marketed since 2011-06-15 · brand TEVA-TRAZODONE · ATC N06AX05 TRAZODONE · form Tablet · route Oral · ingredients TRAZODONE HYDROCHLORIDE 50 MG · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Teva-Trazodone: Formulary list price $0.0554/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0554 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18191 · Verify on the e-Formulary ↗ (DIN 02144263)

Source record
DIN 02144263: Teva-Trazodone Raw flags: sec3=Y Item: 281604040; group id 472; item number 1185; lccId None; manufacturer id TEV Source form: Tab; strength: 50mg Recorded listing: General benefit Source prices (unrounded): $0.0554; ministry $0.0554 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02144263 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18191
Interchangeable products
Apo-Trazodone · DIN 02147637 · $0.0554 Desyrel · DIN 00579351 · not recorded Jamp Trazodone · DIN 02442809 · $0.0554 PMS-Trazodone · DIN 01937227 · $0.0554 Trazodone · DIN 02348772 · $0.0554
Shortage status: resolved shortage (ended 2026-03-18); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02144263
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Trazodone · DIN 02348772 · 50mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Trazodone · DIN 02348772 Manufacturer: Sanis Health Inc.; listing date 2011-10-25 Health Canada: Marketed since 2014-07-31 · brand TRAZODONE · ATC N06AX05 TRAZODONE · form Tablet · route Oral · ingredients TRAZODONE HYDROCHLORIDE 50 MG · company Sanis health inc · schedule Prescription
Check this DIN again · Health Canada product record

Trazodone: Formulary list price $0.0554/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0554 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83411 · Verify on the e-Formulary ↗ (DIN 02348772)

Source record
DIN 02348772: Trazodone Raw flags: sec3=Y Item: 281604040; group id 472; item number 1185; lccId None; manufacturer id SAI Source form: Tab; strength: 50mg Recorded listing: General benefit Source prices (unrounded): $0.0554; ministry $0.0554 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02348772 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83411
Interchangeable products
Apo-Trazodone · DIN 02147637 · $0.0554 Desyrel · DIN 00579351 · not recorded Jamp Trazodone · DIN 02442809 · $0.0554 PMS-Trazodone · DIN 01937227 · $0.0554 Teva-Trazodone · DIN 02144263 · $0.0554
Shortage status: active shortage (reported 2025-12-08, last updated 2026-01-05); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02348772
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apo-Trazodone · DIN 02147645 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Trazodone · DIN 02147645 Manufacturer: Apotex Inc.; listing date 1996-10-01 Health Canada: Marketed since 1995-12-31 · brand APO-TRAZODONE TABLETS 100MG · ATC N06AX05 TRAZODONE · form Tablet · route Oral · ingredients TRAZODONE HYDROCHLORIDE 100 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Trazodone: Formulary list price $0.0989/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0989 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18045 · Verify on the e-Formulary ↗ (DIN 02147645)

Source record
DIN 02147645: Apo-Trazodone Raw flags: sec3=Y Item: 281604041; group id 472; item number 1186; lccId None; manufacturer id APX Source form: Tab; strength: 100mg Recorded listing: General benefit Source prices (unrounded): $0.0989; ministry $0.0989 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02147645 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18045
Interchangeable products
Desyrel · DIN 00579378 · not recorded Jamp Trazodone · DIN 02442817 · $0.0989 PMS-Trazodone · DIN 01937235 · $0.0989 Teva-Trazodone · DIN 02144271 · $0.0989 Trazodone · DIN 02348780 · $0.0989
Shortage status: resolved shortage (ended 2024-02-29); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02147645
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Jamp Trazodone · DIN 02442817 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp Trazodone · DIN 02442817 Manufacturer: Jamp Pharma Corporation; listing date 2022-01-31 Health Canada: Marketed since 2021-11-19 · brand JAMP TRAZODONE · ATC N06AX05 TRAZODONE · form Tablet · route Oral · ingredients TRAZODONE HYDROCHLORIDE 100 MG · company Jamp pharma corporation · schedule Prescription
Check this DIN again · Health Canada product record

Jamp Trazodone: Formulary list price $0.0989/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0989 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=92727 · Verify on the e-Formulary ↗ (DIN 02442817)

Source record
DIN 02442817: Jamp Trazodone Raw flags: sec3=Y Item: 281604041; group id 472; item number 1186; lccId None; manufacturer id JPC Source form: Tab; strength: 100mg Recorded listing: General benefit Source prices (unrounded): $0.0989; ministry $0.0989 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02442817 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=92727
Interchangeable products
Apo-Trazodone · DIN 02147645 · $0.0989 Desyrel · DIN 00579378 · not recorded PMS-Trazodone · DIN 01937235 · $0.0989 Teva-Trazodone · DIN 02144271 · $0.0989 Trazodone · DIN 02348780 · $0.0989
Shortage status: resolved shortage (ended 2023-08-08); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02442817
Shortage record checked 2026-09-13T08:10:21.292534+00:00

PMS-Trazodone · DIN 01937235 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
PMS-Trazodone · DIN 01937235 Manufacturer: Pharmascience Inc.; listing date 1996-10-01 Health Canada: Marketed since 1993-12-31 · brand PMS TRAZODONE HCL TAB 100MG · ATC N06AX05 TRAZODONE · form Tablet · route Oral · ingredients TRAZODONE HYDROCHLORIDE 100 MG · company Pharmascience inc · schedule Prescription
Check this DIN again · Health Canada product record

PMS-Trazodone: Formulary list price $0.0989/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0989 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13780 · Verify on the e-Formulary ↗ (DIN 01937235)

Source record
DIN 01937235: PMS-Trazodone Raw flags: sec3=Y Item: 281604041; group id 472; item number 1186; lccId None; manufacturer id PMS Source form: Tab; strength: 100mg Recorded listing: General benefit Source prices (unrounded): $0.0989; ministry $0.0989 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=01937235 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13780
Interchangeable products
Apo-Trazodone · DIN 02147645 · $0.0989 Desyrel · DIN 00579378 · not recorded Jamp Trazodone · DIN 02442817 · $0.0989 Teva-Trazodone · DIN 02144271 · $0.0989 Trazodone · DIN 02348780 · $0.0989
Shortage status: resolved shortage (ended 2023-10-20); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01937235
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Teva-Trazodone · DIN 02144271 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Teva-Trazodone · DIN 02144271 Manufacturer: Teva Canada Limited; listing date 1996-10-01 Health Canada: Marketed since 2011-06-15 · brand TEVA-TRAZODONE · ATC N06AX05 TRAZODONE · form Tablet · route Oral · ingredients TRAZODONE HYDROCHLORIDE 100 MG · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Teva-Trazodone: Formulary list price $0.0989/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0989 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18190 · Verify on the e-Formulary ↗ (DIN 02144271)

Source record
DIN 02144271: Teva-Trazodone Raw flags: sec3=Y Item: 281604041; group id 472; item number 1186; lccId None; manufacturer id TEV Source form: Tab; strength: 100mg Recorded listing: General benefit Source prices (unrounded): $0.0989; ministry $0.0989 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02144271 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18190
Interchangeable products
Apo-Trazodone · DIN 02147645 · $0.0989 Desyrel · DIN 00579378 · not recorded Jamp Trazodone · DIN 02442817 · $0.0989 PMS-Trazodone · DIN 01937235 · $0.0989 Trazodone · DIN 02348780 · $0.0989
Shortage status: resolved shortage (ended 2025-11-25); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02144271
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Trazodone · DIN 02348780 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Trazodone · DIN 02348780 Manufacturer: Sanis Health Inc.; listing date 2011-10-25 Health Canada: Marketed since 2014-07-31 · brand TRAZODONE · ATC N06AX05 TRAZODONE · form Tablet · route Oral · ingredients TRAZODONE HYDROCHLORIDE 100 MG · company Sanis health inc · schedule Prescription
Check this DIN again · Health Canada product record

Trazodone: Formulary list price $0.0989/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0989 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83412 · Verify on the e-Formulary ↗ (DIN 02348780)

Source record
DIN 02348780: Trazodone Raw flags: sec3=Y Item: 281604041; group id 472; item number 1186; lccId None; manufacturer id SAI Source form: Tab; strength: 100mg Recorded listing: General benefit Source prices (unrounded): $0.0989; ministry $0.0989 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02348780 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83412
Interchangeable products
Apo-Trazodone · DIN 02147645 · $0.0989 Desyrel · DIN 00579378 · not recorded Jamp Trazodone · DIN 02442817 · $0.0989 PMS-Trazodone · DIN 01937235 · $0.0989 Teva-Trazodone · DIN 02144271 · $0.0989
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02348780
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apo-Trazodone D · DIN 02147653 · 150mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Trazodone D · DIN 02147653 Manufacturer: Apotex Inc.; listing date 1996-10-01 Health Canada: Marketed since 1995-12-31 · brand APO-TRAZODONE D TABLETS 150MG · ATC N06AX05 TRAZODONE · form Tablet · route Oral · ingredients TRAZODONE HYDROCHLORIDE 150 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Trazodone D: Formulary list price $0.1453/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1453 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18040 · Verify on the e-Formulary ↗ (DIN 02147653)

Source record
DIN 02147653: Apo-Trazodone D Raw flags: sec3=Y Item: 281604050; group id 472; item number 1187; lccId None; manufacturer id APX Source form: Tab; strength: 150mg Recorded listing: General benefit Source prices (unrounded): $0.1453; ministry $0.1453 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02147653 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18040
Interchangeable products
Desyrel Dividose · DIN 00702277 · not recorded Jamp Trazodone · DIN 02442825 · $0.1453 Teva-Trazodone · DIN 02144298 · $0.1453 Trazodone · DIN 02348799 · $0.1453
Shortage status: shortage reported ended 2026-08-28 (report last updated 2026-08-28); confirm supply with the pharmacy; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02147653
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Jamp Trazodone · DIN 02442825 · 150mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp Trazodone · DIN 02442825 Manufacturer: Jamp Pharma Corporation; listing date 2022-01-31 Health Canada: Marketed since 2021-11-19 · brand JAMP TRAZODONE · ATC N06AX05 TRAZODONE · form Tablet · route Oral · ingredients TRAZODONE HYDROCHLORIDE 150 MG · company Jamp pharma corporation · schedule Prescription
Check this DIN again · Health Canada product record

Jamp Trazodone: Formulary list price $0.1453/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1453 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=92729 · Verify on the e-Formulary ↗ (DIN 02442825)

Source record
DIN 02442825: Jamp Trazodone Raw flags: sec3=Y Item: 281604050; group id 472; item number 1187; lccId None; manufacturer id JPC Source form: Tab; strength: 150mg Recorded listing: General benefit Source prices (unrounded): $0.1453; ministry $0.1453 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02442825 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=92729
Interchangeable products
Apo-Trazodone D · DIN 02147653 · $0.1453 Desyrel Dividose · DIN 00702277 · not recorded Teva-Trazodone · DIN 02144298 · $0.1453 Trazodone · DIN 02348799 · $0.1453
Shortage status: resolved shortage (ended 2023-08-08); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02442825
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Teva-Trazodone · DIN 02144298 · 150mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Teva-Trazodone · DIN 02144298 Manufacturer: Teva Canada Limited; listing date 1996-10-01 Health Canada: Marketed since 2011-06-15 · brand TEVA-TRAZODONE · ATC N06AX05 TRAZODONE · form Tablet · route Oral · ingredients TRAZODONE HYDROCHLORIDE 150 MG · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Teva-Trazodone: Formulary list price $0.1453/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1453 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18189 · Verify on the e-Formulary ↗ (DIN 02144298)

Source record
DIN 02144298: Teva-Trazodone Raw flags: sec3=Y Item: 281604050; group id 472; item number 1187; lccId None; manufacturer id TEV Source form: Tab; strength: 150mg Recorded listing: General benefit Source prices (unrounded): $0.1453; ministry $0.1453 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02144298 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18189
Interchangeable products
Apo-Trazodone D · DIN 02147653 · $0.1453 Desyrel Dividose · DIN 00702277 · not recorded Jamp Trazodone · DIN 02442825 · $0.1453 Trazodone · DIN 02348799 · $0.1453
Shortage status: resolved shortage (ended 2026-06-03); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02144298
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Trazodone · DIN 02348799 · 150mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Trazodone · DIN 02348799 Manufacturer: Sanis Health Inc.; listing date 2011-10-25 Health Canada: Marketed since 2014-07-31 · brand TRAZODONE · ATC N06AX05 TRAZODONE · form Tablet · route Oral · ingredients TRAZODONE HYDROCHLORIDE 150 MG · company Sanis health inc · schedule Prescription
Check this DIN again · Health Canada product record

Trazodone: Formulary list price $0.1453/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1453 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83413 · Verify on the e-Formulary ↗ (DIN 02348799)

Source record
DIN 02348799: Trazodone Raw flags: sec3=Y Item: 281604050; group id 472; item number 1187; lccId None; manufacturer id SAI Source form: Tab; strength: 150mg Recorded listing: General benefit Source prices (unrounded): $0.1453; ministry $0.1453 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02348799 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83413
Interchangeable products
Apo-Trazodone D · DIN 02147653 · $0.1453 Desyrel Dividose · DIN 00702277 · not recorded Jamp Trazodone · DIN 02442825 · $0.1453 Teva-Trazodone · DIN 02144298 · $0.1453
Shortage status: resolved shortage (ended 2024-04-22); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02348799
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Desyrel · DIN 00579351 · 50mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2010-05-14 — choose a marketed DIN from the same-category list.Discontinued 2010-05-14 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2010-05-14 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2010-05-14 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Desyrel · DIN 00579351 Manufacturer: Bristol Myers Squibb Canada Inc; listing date 1996-10-01 Health Canada: Cancelled post market since 2010-05-14 · brand DESYREL TAB 50MG · ATC N06AX05 TRAZODONE · form Tablet · route Oral · ingredients TRAZODONE HYDROCHLORIDE 50 MG · company Bristol-myers squibb canada · schedule Prescription
Check this DIN again · Health Canada product record

Desyrel: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5118 · Verify on the e-Formulary ↗ (DIN 00579351)

Source record
DIN 00579351: Desyrel Raw flags: notABenefit=Y, sec3=Y Item: 281604040; group id 472; item number 1185; lccId None; manufacturer id BQU Source form: Tab; strength: 50mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00579351 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5118
Interchangeable products
Apo-Trazodone · DIN 02147637 · $0.0554 Jamp Trazodone · DIN 02442809 · $0.0554 PMS-Trazodone · DIN 01937227 · $0.0554 Teva-Trazodone · DIN 02144263 · $0.0554 Trazodone · DIN 02348772 · $0.0554
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00579351
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2010-05-14 — choose a marketed DIN from the same-category list.

Desyrel · DIN 00579378 · 100mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2010-09-07 — choose a marketed DIN from the same-category list.Discontinued 2010-09-07 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2010-09-07 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2010-09-07 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Desyrel · DIN 00579378 Manufacturer: Bristol Myers Squibb Canada Inc; listing date 1996-10-01 Health Canada: Cancelled post market since 2010-09-07 · brand DESYREL TAB 100MG · ATC N06AX05 TRAZODONE · form Tablet · route Oral · ingredients TRAZODONE HYDROCHLORIDE 100 MG · company Bristol-myers squibb canada · schedule Prescription
Check this DIN again · Health Canada product record

Desyrel: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5119 · Verify on the e-Formulary ↗ (DIN 00579378)

Source record
DIN 00579378: Desyrel Raw flags: notABenefit=Y, sec3=Y Item: 281604041; group id 472; item number 1186; lccId None; manufacturer id BQU Source form: Tab; strength: 100mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00579378 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5119
Interchangeable products
Apo-Trazodone · DIN 02147645 · $0.0989 Jamp Trazodone · DIN 02442817 · $0.0989 PMS-Trazodone · DIN 01937235 · $0.0989 Teva-Trazodone · DIN 02144271 · $0.0989 Trazodone · DIN 02348780 · $0.0989
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00579378
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2010-09-07 — choose a marketed DIN from the same-category list.

Desyrel Dividose · DIN 00702277 · 150mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2010-01-05 — choose a marketed DIN from the same-category list.Discontinued 2010-01-05 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2010-01-05 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2010-01-05 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Desyrel Dividose · DIN 00702277 Manufacturer: Bristol Myers Squibb Canada Inc; listing date 1996-10-01 Health Canada: Cancelled post market since 2010-01-05 · brand DESYREL DIVIDOSE TABLET 150 MG · ATC N06AX05 TRAZODONE · form Tablet · route Oral · ingredients TRAZODONE HYDROCHLORIDE 150 MG · company Bristol-myers squibb canada · schedule Prescription
Check this DIN again · Health Canada product record

Desyrel Dividose: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=9503 · Verify on the e-Formulary ↗ (DIN 00702277)

Source record
DIN 00702277: Desyrel Dividose Raw flags: notABenefit=Y, sec3=Y Item: 281604050; group id 472; item number 1187; lccId None; manufacturer id BQU Source form: Tab; strength: 150mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00702277 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=9503
Interchangeable products
Apo-Trazodone D · DIN 02147653 · $0.1453 Jamp Trazodone · DIN 02442825 · $0.1453 Teva-Trazodone · DIN 02144298 · $0.1453 Trazodone · DIN 02348799 · $0.1453
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00702277
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2010-01-05 — choose a marketed DIN from the same-category list.
Other drugs in the same formulary class (28:16:04 Antidepressants) and how they are covered

Matched class: 28:16:04 Antidepressants

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: AMITRIPTYLINE, CLOMIPRAMINE HCL, FLUVOXAMINE MALEATE, NORTRIPTYLINE, PHENELZINE SULFATE, SERTRALINE HCL, TRANYLCYPROMINE SULFATE, VENLAFAXINE HCL, VORTIOXETINE HYDROBROMIDE Some products covered without a code (check the product listing): CITALOPRAM HYDROBROMIDE, DESIPRAMINE, DOXEPIN HCL, DULOXETINE, ESCITALOPRAM, FLUOXETINE HCL, IMIPRAMINE, MIRTAZAPINE, MOCLOBEMIDE, PAROXETINE HCL, TRIMIPRAMINE 28:16:04 Antidepressants

DULOXETINE

· 38 products · Listed, not a benefit (2), General benefit (36) · strengths: 30mg, 60mg · DR Cap

MIRTAZAPINE

· 25 products · General benefit (16), Off-Formulary Interchangeable, not an ODB benefit (9) · strengths: 15mg, 30mg, 45mg · Orally Disintegrating Tab, Tab

VENLAFAXINE HCL

· 45 products · General benefit · strengths: 37.5mg, 75mg, 150mg · ER Cap

VORTIOXETINE HYDROBROMIDE

· 6 products · General benefit · strengths: 5mg, 10mg, 20mg · Tab

BUPROPION HCL

· 12 products · Limited Use, codes 315 (10), Listed, not a benefit (2) · strengths: 150mg, 300mg, 100mg · ER Tab, Tab

DESVENLAFAXINE

· 18 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 50mg, 100mg · ER Tab

VILAZODONE HYDROCHLORIDE

· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 10mg, 20mg, 40mg · Tab

AMITRIPTYLINE

· 12 products · General benefit · strengths: 10mg, 25mg, 50mg · Tab

CITALOPRAM HYDROBROMIDE

· 51 products · Off-Formulary Interchangeable, not an ODB benefit (9), General benefit (42) · strengths: 10mg, 20mg, 40mg · Tab

CLOMIPRAMINE HCL

· 5 products · General benefit · strengths: 25mg, 50mg, 10mg · Tab

DESIPRAMINE

· 7 products · Listed, not a benefit (4), General benefit (3) · strengths: 25mg, 50mg, 75mg · Tab

DOXEPIN HCL

· 20 products · General benefit (12), Off-Formulary Interchangeable, not an ODB benefit (8) · strengths: 10mg, 25mg, 50mg, 75mg, 100mg · Cap Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 28:16:04 and 12 more
Full class listing Related classes: 28:08:04 Nonsteroidal Anti-Inflammatory Agents, 28:08:08 Opiate Agonists, 28:08:12 Opiate Partial Agonists, 28:08:92 Miscellaneous Analgesics and Antipyretics, 28:16:08 Tranquilizers, 28:16:12 Other Psychotropics, 28:36:08 Anticholinergic Agents, 28:36:20 Dopamine Receptor Agonists Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE pms-TRAZODONE (trazodone hydrochloride) is of value in the symptomatic relief of depressive illness. Geriatrics (> 65 years of age): Use with caution in geriatric patients. See WARNINGS & PRECAUTIONS: Special Population. Pediatrics (< 18 years of age): Safety and efficacy have not been established in patients below 18 years of age. pms-TRAZODONE is not indicated in this age group. https://pdf.hres.ca/dpd_pm/00030282.PDF PM date: April 15, 2015 Source product: PMS TRAZODONE HCL TAB 50MG; DIN 01937227; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Apo-Trazodone · DIN 02147637 Shortage status: shortage reported ended 2026-08-28 (report last updated 2026-08-28); confirm supply with the pharmacy; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02147637

Check this DIN again

Trazodone · DIN 02348772 Shortage status: active shortage (reported 2025-12-08, last updated 2026-01-05); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02348772

Check this DIN again

Apo-Trazodone D · DIN 02147653 Shortage status: shortage reported ended 2026-08-28 (report last updated 2026-08-28); confirm supply with the pharmacy; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02147653

Check this DIN again

Other review policies

For Desyrel, Desyrel Dividose: no applicable EAP criteria are held and no ODB benefit is established. These policies do not establish coverage.

For rare, immediately life-, limb- or organ-threatening circumstances, the Compassionate Review Policy may consider an unfunded drug or indication, subject to its criteria and without bypassing the drug review process. Compassionate Review Policy

Compassionate Review Policy: source quote
Where there are rare clinical circumstances in immediately life, limb, or organ-threatening conditions, the Executive Officer will also consider requests for drugs or indications in situations where there has not been a decision by the Executive Officer to provide funding of the drug or indication as part of the Ontario Drug Benefit program (and the EAP), and the drug or indication requested would not circumvent the established review process for new drugs or indications as part of the drug submission process for listing within the Ontario Drug Benefit program. Requests must meet the criteria for the Compassionate Review Policy.

Ontario source; updated September 15, 2026

For cancer drugs, Case-by-Case Review considers rare, immediately life-threatening circumstances when no satisfactory funded treatment exists; its criteria and application process apply. Case-by-Case Review (cancer drugs)

Case-by-Case Review (cancer drugs): source quote
Note: Requests for cancer drugs are considered under the Case-by-Case Review Program (CBCRP) which is administered by Ontario Health (Cancer Care Ontario) on behalf of the Ministry of Health. The CBCRP considers funding requests for drugs (both oral therapies and injectable drugs) for the treatment of cancer in patients who have a rare clinical circumstance that is immediately life-threatening (death is likely within a matter of months) and who require treatment with an unfunded drug, because there is no other satisfactory and funded treatment. Please refer to the Ontario Health website for information on the application process, FAQs, eligibility criteria and program policies.

Ontario source; updated September 15, 2026